FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4244493954> ?p ?o ?g. }

• W4244493954 endingPage "517" @default.
• W4244493954 startingPage "516" @default.
• W4244493954 abstract "BJU InternationalVolume 101, Issue 4 p. 516-517 Reply Stephen Jeffery, Stephen Jeffery Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this authorMichelle Fynes, Michelle Fynes Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this authorKate Wang, Kate Wang Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this authorRoland Morley, Roland Morley Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this author Stephen Jeffery, Stephen Jeffery Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this authorMichelle Fynes, Michelle Fynes Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this authorKate Wang, Kate Wang Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this authorRoland Morley, Roland Morley Department of Pelvic Floor Reconstruction and Urogynaecology, St George’s Hospital, and *Department of Urology, Kingston Hospital, London, UKSearch for more papers by this author First published: 24 January 2008 https://doi.org/10.1111/j.1464-410X.2008.07447_4.xRead the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Schurch B, Stöhrer M, Kramer D, Schmid M, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hperrefelexia in spinal cord injured patients: A new alternative to anticholoinergic drugs? Preliminary results. J Urol 2005; 174: 196– 200 2 Patel AK, Patterson JM, Chapple CR. Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: A critical analysis of results. Eur Urol 2006; 50: 684– 709 3 Reitz A, Stöhrer M, Kramer G et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol 2004; 45: 510– 5 4 Popat R, Apostolides A, Kalsi V, Gonzales G, Fowler CJ, Dasgupta P. A comparison beween the response of patients with idiopathic detrusor overactivity and neurogenic Detrusor Overactivity To The first intradetrusor injection Of botulinum-A toxin. J Urol 2005; 174: 984– 9 5 Ruffion A, Capelle O, Paparel P, Leriche B, Leriche A, Grise P. What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int 2006; 97: 1030– 4 6 Patki PS, Hamid R, Arumugam K, Shah PJ, Craggs M. Botulinum toxin-type A in the treatment of drug-resistant neurogenic detrusor overactivity secondary to traumatic spinal cord injury. BJU Int 2006; 98: 77– 82 7 Schurch B, De Seze M, Denys P et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomised, placebo controlled 6-month study. J Urol 2005; 174: 196– 200 8 Werner M, Schmid DM, Schussler B. Efficacy of Botulinum-A toxin in the treatment of detrusor overactivity incontinence: a prospective nonrandomized study. Am J Obstet Gynecol 2005; 192: 1735– 40 9 Smith CP, Nishiguchi J, O’Leary M, Yoshimura N, Chancellor MB. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 2005; 65: 37– 41 10 Schulte-Baukloh H, Schobert J, Stolze T, Sturzebecher B, Weiss C, Knispel HH. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis. Neurourol Urodyn 2006; 25: 110– 5 11 Kalsi V, Apostolidis A, Popat R, Gonzales G, Fowler CJ, Dasgupta P. Quality of life changes in patients with neurogenic versus idiopathic detrusor overactivity after intradetrusor injections of botulinum neurotoxin type A and correlations with lower urinary tract symptoms and urodynamic changes. Eur Urol 2006; 49: 528– 35 12 Rajkumar GN, Small DR, Mustafa AW, Conn G. A prospective study to evaluate the safety, tolerability, efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity. BJU Int 2005; 96: 848– 52 13 Chapple C, Patel A. Botulinum toxin-new mechanisms, new therapeutic directions? Eur Urol 2006; 49: 606– 8 14 Apostolidis A, Dasgupta P, Fowler CJ. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 2006; 49: 644– 50 15 Sahai A, Khan MS, Dasgupta P. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial. J Urol 2007; 177: 2231– 6 16 Jeffery S, Fynes M, Lee F, Wang K, Williams L, Morley R. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 2007; 100: 1302– 6 17 Karsenty G, Elzayat E, Delapparent T, St-Denis B, Lemieux MC, Corcos J. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux. J Urol 2007; 177: 1011– 4 18 Kuo HC. Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 2007; 178: 1359– 63 Volume101, Issue4February 2008Pages 516-517 ReferencesRelatedInformation" @default.
• W4244493954 created "2022-05-12" @default.
• W4244493954 creator A5005274209 @default.
• W4244493954 creator A5042605047 @default.
• W4244493954 creator A5050335579 @default.
• W4244493954 creator A5066110010 @default.
• W4244493954 date "2008-01-24" @default.
• W4244493954 modified "2023-09-28" @default.
• W4244493954 title "Reply" @default.
• W4244493954 cites W1976363592 @default.
• W4244493954 cites W1983252944 @default.
• W4244493954 cites W1987648603 @default.
• W4244493954 cites W1995640447 @default.
• W4244493954 cites W2002037387 @default.
• W4244493954 cites W2043653788 @default.
• W4244493954 cites W2044720944 @default.
• W4244493954 cites W2046590607 @default.
• W4244493954 cites W2052438064 @default.
• W4244493954 cites W2058243451 @default.
• W4244493954 cites W2062168648 @default.
• W4244493954 cites W2079015737 @default.
• W4244493954 cites W2079232828 @default.
• W4244493954 cites W2107593389 @default.
• W4244493954 cites W2117482584 @default.
• W4244493954 cites W2126110442 @default.
• W4244493954 cites W4256631357 @default.
• W4244493954 doi "https://doi.org/10.1111/j.1464-410x.2008.07447_4.x" @default.
• W4244493954 hasPublicationYear "2008" @default.
• W4244493954 type Work @default.
• W4244493954 citedByCount "0" @default.
• W4244493954 crossrefType "journal-article" @default.
• W4244493954 hasAuthorship W4244493954A5005274209 @default.
• W4244493954 hasAuthorship W4244493954A5042605047 @default.
• W4244493954 hasAuthorship W4244493954A5050335579 @default.
• W4244493954 hasAuthorship W4244493954A5066110010 @default.
• W4244493954 hasBestOaLocation W42444939541 @default.
• W4244493954 hasConcept C159110408 @default.
• W4244493954 hasConcept C2780724011 @default.
• W4244493954 hasConcept C2992019943 @default.
• W4244493954 hasConcept C52119013 @default.
• W4244493954 hasConcept C61434518 @default.
• W4244493954 hasConcept C67101536 @default.
• W4244493954 hasConcept C71924100 @default.
• W4244493954 hasConcept C95457728 @default.
• W4244493954 hasConceptScore W4244493954C159110408 @default.
• W4244493954 hasConceptScore W4244493954C2780724011 @default.
• W4244493954 hasConceptScore W4244493954C2992019943 @default.
• W4244493954 hasConceptScore W4244493954C52119013 @default.
• W4244493954 hasConceptScore W4244493954C61434518 @default.
• W4244493954 hasConceptScore W4244493954C67101536 @default.
• W4244493954 hasConceptScore W4244493954C71924100 @default.
• W4244493954 hasConceptScore W4244493954C95457728 @default.
• W4244493954 hasIssue "4" @default.
• W4244493954 hasLocation W42444939541 @default.
• W4244493954 hasOpenAccess W4244493954 @default.
• W4244493954 hasPrimaryLocation W42444939541 @default.
• W4244493954 hasRelatedWork W2002347000 @default.
• W4244493954 hasRelatedWork W2026095104 @default.
• W4244493954 hasRelatedWork W2061619006 @default.
• W4244493954 hasRelatedWork W2510700473 @default.
• W4244493954 hasRelatedWork W2613637409 @default.
• W4244493954 hasRelatedWork W2980093723 @default.
• W4244493954 hasRelatedWork W3005450714 @default.
• W4244493954 hasRelatedWork W34418945 @default.
• W4244493954 hasRelatedWork W4238308949 @default.
• W4244493954 hasRelatedWork W4322718135 @default.
• W4244493954 hasVolume "101" @default.
• W4244493954 isParatext "false" @default.
• W4244493954 isRetracted "false" @default.
• W4244493954 workType "article" @default.